Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models.
在黑色素瘤模型中,针对微小残留病灶的TAZ-TEAD靶向治疗可延长靶向治疗的持续时间。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-64682-7
Ott Connor A, Purwin Timothy J, Chen Pan-Yu, Chowdhury Somenath, Mellor George L, Luo Kristine, Mersky Glenn L, Tiago Manoela, Madden William D, Varney Scott D, Erkes Dan A, Lamar John, Capparelli Claudia, Bollag Gideon, Aplin Andrew E